Yigal Nochomovitz
Stock Analyst at Citi
(4.43)
# 1,126
Out of 4,423 analysts
736
Total ratings
43.5%
Success rate
9.3%
Average return
Main Sectors:
Stocks Rated by Yigal Nochomovitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NBIX Neurocrine Biosciences | Maintained: Buy | $246 | $158.29 | +55.41% | 10 | Jun 15, 2026 | |
| TVTX Travere Therapeutics | Rated: Buy | $62 → $70 | $55.15 | +26.93% | 18 | Jun 14, 2026 | |
| MIRM Mirum Pharmaceuticals | Maintained: Buy | $145 | $107.13 | +35.35% | 2 | Jun 14, 2026 | |
| ONC BeOne Medicines AG | Maintained: Buy | $405 → $453 | $270.15 | +67.68% | 7 | Jun 12, 2026 | |
| BMEA Biomea Fusion | Maintained: Buy | $7 | $1.18 | +493.22% | 19 | Jun 11, 2026 | |
| CRBU Caribou Biosciences | Maintained: Buy | $8 | $1.64 | +387.80% | 22 | Jun 11, 2026 | |
| STTK Shattuck Labs | Rated: Buy | $7 → $18 | $4.95 | +263.64% | 13 | Jun 9, 2026 | |
| SPTX Seaport Therapeutics | Rated: Buy | $35 | $18.17 | +92.63% | 3 | Jun 8, 2026 | |
| SLDB Solid Biosciences | Rated: Buy | $14 | $8.33 | +68.07% | 6 | Jun 4, 2026 | |
| AVBP ArriVent BioPharma | Maintained: Buy | $43 | $31.74 | +35.48% | 13 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 | $13.75 | +190.91% | 18 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $62 | $9.51 | +551.95% | 13 | May 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $12.99 | +61.66% | 1 | May 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $69 → $81 | $32.91 | +146.13% | 18 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $26 → $20 | $6.15 | +225.20% | 14 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $41 | $19.78 | +107.28% | 11 | May 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $2.3 → $3.1 | $2.01 | +54.23% | 33 | May 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $32 | $21.62 | +48.01% | 6 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $23.14 | +51.25% | 31 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $47 → $44 | $18.18 | +142.02% | 27 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $13 | $17.53 | -25.84% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $80 → $82 | $54.09 | +51.60% | 25 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $45 | $27.44 | +63.99% | 29 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $371 → $378 | $348.06 | +8.60% | 11 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $17 → $16 | $8.49 | +88.46% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $24 | $7.67 | +212.91% | 24 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $276 → $282 | $274.88 | +2.59% | 3 | Apr 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $31.23 | +108.13% | 19 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $22 → $26 | $8.31 | +212.88% | 8 | Mar 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $7 → $9 | $9.78 | -7.98% | 5 | Mar 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $33 → $35 | $13.58 | +157.73% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 | $18.70 | +124.60% | 2 | Mar 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $44 → $45 | $24.31 | +85.11% | 29 | Mar 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $7 → $8 | $7.53 | +6.24% | 20 | Mar 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $51 → $57 | $19.00 | +200.00% | 16 | Mar 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 → $14 | $6.05 | +131.40% | 24 | Jan 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $1.83 | +446.45% | 7 | Sep 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $2 → $4 | $1.89 | n/a | 10 | Mar 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $11 | $2.98 | n/a | 9 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $11 → $8 | $1.48 | n/a | 8 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $10 | $0.0201 | n/a | 5 | Sep 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $16 → $14 | $4.13 | n/a | 16 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 → $1.2 | $2.27 | n/a | 18 | Jun 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 | $2.09 | n/a | 11 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 | $1.96 | n/a | 16 | Dec 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $35 → $10 | $10.07 | n/a | 17 | Nov 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $8 | $1.81 | n/a | 4 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $2.06 | n/a | 6 | Sep 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $63 | $78.98 | n/a | 1 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 → $2 | $1.91 | n/a | 3 | Nov 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €12.00 | $1.61 | n/a | 1 | Sep 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $30 → $8 | $45.10 | n/a | 5 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $8 → $11 | $7.56 | n/a | 24 | Sep 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $26 → $2 | $0.71 | n/a | 5 | Aug 21, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $9 | $1.07 | n/a | 1 | Mar 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.000001 | n/a | 4 | Dec 29, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $0.000001 | n/a | 6 | Aug 13, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.12 | n/a | 2 | Apr 27, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $32 | $0.6217 | n/a | 6 | Mar 31, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $49 | $9.43 | n/a | 6 | Mar 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $53 | $9.02 | n/a | 5 | Mar 16, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $10 | $3.51 | n/a | 1 | Jan 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.05 | n/a | 3 | Nov 23, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2,119.00 | n/a | 3 | Nov 21, 2014 |
Neurocrine Biosciences
Jun 15, 2026
Maintained: Buy
Price Target: $246
Current: $158.29
Upside: +55.41%
Travere Therapeutics
Jun 14, 2026
Rated: Buy
Price Target: $62 → $70
Current: $55.15
Upside: +26.93%
Mirum Pharmaceuticals
Jun 14, 2026
Maintained: Buy
Price Target: $145
Current: $107.13
Upside: +35.35%
BeOne Medicines AG
Jun 12, 2026
Maintained: Buy
Price Target: $405 → $453
Current: $270.15
Upside: +67.68%
Biomea Fusion
Jun 11, 2026
Maintained: Buy
Price Target: $7
Current: $1.18
Upside: +493.22%
Caribou Biosciences
Jun 11, 2026
Maintained: Buy
Price Target: $8
Current: $1.64
Upside: +387.80%
Shattuck Labs
Jun 9, 2026
Rated: Buy
Price Target: $7 → $18
Current: $4.95
Upside: +263.64%
Seaport Therapeutics
Jun 8, 2026
Rated: Buy
Price Target: $35
Current: $18.17
Upside: +92.63%
Solid Biosciences
Jun 4, 2026
Rated: Buy
Price Target: $14
Current: $8.33
Upside: +68.07%
ArriVent BioPharma
Jun 3, 2026
Maintained: Buy
Price Target: $43
Current: $31.74
Upside: +35.48%
May 31, 2026
Maintained: Buy
Price Target: $40
Current: $13.75
Upside: +190.91%
May 31, 2026
Maintained: Buy
Price Target: $62
Current: $9.51
Upside: +551.95%
May 18, 2026
Initiated Coverage: Buy
Price Target: $21
Current: $12.99
Upside: +61.66%
May 13, 2026
Rated: Buy
Price Target: $69 → $81
Current: $32.91
Upside: +146.13%
May 13, 2026
Rated: Buy
Price Target: $26 → $20
Current: $6.15
Upside: +225.20%
May 13, 2026
Reiterated: Buy
Price Target: $41
Current: $19.78
Upside: +107.28%
May 11, 2026
Maintained: Buy
Price Target: $2.3 → $3.1
Current: $2.01
Upside: +54.23%
May 8, 2026
Maintained: Buy
Price Target: $33 → $32
Current: $21.62
Upside: +48.01%
May 8, 2026
Reiterated: Buy
Price Target: $35
Current: $23.14
Upside: +51.25%
May 8, 2026
Maintained: Buy
Price Target: $47 → $44
Current: $18.18
Upside: +142.02%
May 6, 2026
Maintained: Sell
Price Target: $13
Current: $17.53
Upside: -25.84%
May 6, 2026
Rated: Buy
Price Target: $80 → $82
Current: $54.09
Upside: +51.60%
May 5, 2026
Maintained: Buy
Price Target: $45
Current: $27.44
Upside: +63.99%
May 5, 2026
Rated: Buy
Price Target: $371 → $378
Current: $348.06
Upside: +8.60%
May 5, 2026
Rated: Buy
Price Target: $17 → $16
Current: $8.49
Upside: +88.46%
May 1, 2026
Rated: Buy
Price Target: $21 → $24
Current: $7.67
Upside: +212.91%
Apr 15, 2026
Rated: Buy
Price Target: $276 → $282
Current: $274.88
Upside: +2.59%
Apr 13, 2026
Maintained: Buy
Price Target: $65
Current: $31.23
Upside: +108.13%
Mar 18, 2026
Rated: Buy
Price Target: $22 → $26
Current: $8.31
Upside: +212.88%
Mar 10, 2026
Rated: Buy
Price Target: $7 → $9
Current: $9.78
Upside: -7.98%
Mar 9, 2026
Maintained: Buy
Price Target: $33 → $35
Current: $13.58
Upside: +157.73%
Mar 9, 2026
Maintained: Buy
Price Target: $42
Current: $18.70
Upside: +124.60%
Mar 5, 2026
Rated: Buy
Price Target: $44 → $45
Current: $24.31
Upside: +85.11%
Mar 4, 2026
Rated: Hold
Price Target: $7 → $8
Current: $7.53
Upside: +6.24%
Mar 2, 2026
Maintained: Buy
Price Target: $51 → $57
Current: $19.00
Upside: +200.00%
Jan 8, 2026
Maintained: Buy
Price Target: $11 → $14
Current: $6.05
Upside: +131.40%
Sep 3, 2025
Maintained: Buy
Price Target: $10
Current: $1.83
Upside: +446.45%
Mar 7, 2025
Upgraded: Buy
Price Target: $2 → $4
Current: $1.89
Upside: n/a
Dec 11, 2024
Maintained: Buy
Price Target: $16 → $11
Current: $2.98
Upside: n/a
Dec 4, 2024
Rated: Buy
Price Target: $11 → $8
Current: $1.48
Upside: n/a
Sep 12, 2024
Maintained: Buy
Price Target: $12 → $10
Current: $0.0201
Upside: n/a
Aug 15, 2024
Maintained: Buy
Price Target: $16 → $14
Current: $4.13
Upside: n/a
Jun 17, 2024
Maintained: Hold
Price Target: $3.5 → $1.2
Current: $2.27
Upside: n/a
May 15, 2024
Maintained: Buy
Price Target: $10
Current: $2.09
Upside: n/a
Dec 4, 2023
Maintained: Buy
Price Target: $8
Current: $1.96
Upside: n/a
Nov 22, 2023
Maintained: Sell
Price Target: $35 → $10
Current: $10.07
Upside: n/a
Sep 18, 2023
Maintained: Buy
Price Target: $12 → $8
Current: $1.81
Upside: n/a
Sep 18, 2023
Maintained: Hold
Price Target: $1.5 → $1
Current: $2.06
Upside: n/a
May 24, 2023
Rated: Buy
Price Target: $63
Current: $78.98
Upside: n/a
Nov 28, 2022
Maintained: Buy
Price Target: $5 → $2
Current: $1.91
Upside: n/a
Sep 16, 2022
Maintained: Buy
Price Target: €12.00
Current: $1.61
Upside: n/a
Apr 5, 2022
Downgraded: Hold
Price Target: $30 → $8
Current: $45.10
Upside: n/a
Sep 27, 2021
Upgraded: Buy
Price Target: $8 → $11
Current: $7.56
Upside: n/a
Aug 21, 2019
Downgraded: Sell
Price Target: $26 → $2
Current: $0.71
Upside: n/a
Mar 20, 2019
Initiated Coverage: Hold
Price Target: $9
Current: $1.07
Upside: n/a
Dec 29, 2016
Downgraded: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Aug 13, 2015
Initiated Coverage: Hold
Price Target: n/a
Current: $0.000001
Upside: n/a
Apr 27, 2015
Rated: Hold
Price Target: n/a
Current: $4.12
Upside: n/a
Mar 31, 2015
Maintained: Buy
Price Target: $32
Current: $0.6217
Upside: n/a
Mar 30, 2015
Reiterated: Buy
Price Target: $49
Current: $9.43
Upside: n/a
Mar 16, 2015
Reiterated: Buy
Price Target: $53
Current: $9.02
Upside: n/a
Jan 9, 2015
Initiated Coverage: Buy
Price Target: $10
Current: $3.51
Upside: n/a
Nov 23, 2014
Rated: Hold
Price Target: n/a
Current: $8.05
Upside: n/a
Nov 21, 2014
Rated: Hold
Price Target: n/a
Current: $2,119.00
Upside: n/a